CSIMarket Company Name, Ticker, Competitors, else..
 
Onkure Therapeutics Inc   (NASDAQ: OKUR)
 

Onkure Therapeutics Inc's Suppliers Performance

OKUR's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
OKUR Costs vs Sales of Suppliers Growth

• More on OKUR Suppliers






Onkure Therapeutics Inc's Comment on Supply Chain


The company sources raw materials that are commonly available from multiple suppliers. It currently relies on contract manufacturing organizations (CMOs) for the drug product of OKI-219 and may engage additional CMOs in the future. The company is developing its supply chain and intends to establish framework agreements with third-party CMOs to supply required quantities of active pharmaceutical ingredient (API) and drug product on a project-by-project basis. It also plans to explore adding backup suppliers for intermediates, API, and drug product for OKI-219 and future candidates to mitigate supply disruptions.

Onkure Therapeutics Inc's Comment on Supply Chain


The company sources raw materials that are commonly available from multiple suppliers. It currently relies on contract manufacturing organizations (CMOs) for the drug product of OKI-219 and may engage additional CMOs in the future. The company is developing its supply chain and intends to establish framework agreements with third-party CMOs to supply required quantities of active pharmaceutical ingredient (API) and drug product on a project-by-project basis. It also plans to explore adding backup suppliers for intermediates, API, and drug product for OKI-219 and future candidates to mitigate supply disruptions.







OKUR's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Onkure Therapeutics Inc 144.62 2.82 -58.71 45
SUBTOTAL 0.00 0.00 0.00 -


Sources: Onkure Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Onkure Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.